Martin Health System Unveils Xenex Germ-Zapping Robot™ more

Jesuit High School Alumnus Donates Xenex Germ-Zapping Robot to His Alma Mater more

BiO2 Medical Announces Successful Completion of the Angel® Catheter Pivotal Clinical Trial more

Xenex Awarded Premier, Inc. Group Purchasing Contract to Offer Germ-Zapping Robot™ Room Disinfection Technology to Premier Member Hospitals more

SA bioscience companies strike new deal to expand scope of stem cell research more

TFS Corporation share price flat despite soaring earnings more

TFS Corporation doubles quarterly profit more

Innovation makes money grow on trees more

Xenex Germ-Zapping Robot™ Destroys Ebola Virus & Anthrax Spores in New Study Performed at Texas Biomed Biosafety Level 4 Lab more

Indian sandalwood oil producer ramps up production to supply new markets more

Cytocentrics Inc. wins Innovator Award at recent event more

Key Opinion Leader (KOL) Calls for New Standard to Close Port-Site Hernias in Lap and Robotic Surgeries more

Surgical Site Infections Decrease 100% after Trinity Medical Center Implements Infection Control Bundle more

Court Order Requires Tru-D to Cease False and Misleading Statements more

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration more

San Antonio biotech firm CEO is heading west more

Sandalwood grower smells a fortune more

Explore the UV LED market that is expected to reach USD 369.58 million by 2020 more

Ten Life Sciences Companies to Watch in Central Texas more

San Antonio’s Xenex signs national contract with HealthTrust more

Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio more

Benzac® Intensive Spot Treatment Named Best Acne Treatment of 2015 by HEALTH Magazine more

neoSurgical® Reports Commercial Milestone of 2000 US Procedures more

Launch of latest hyaluronic acid based filler range more

Galderma Laboratories Announces the Nationwide Availability of Benzac® more

BioMed SA Celebrates 10th Anniversary more

TFS completes US pharma acquisition more

Finally, Good News for Anyone Looking for a Gentle Acne Treatment more

4th Peer-Reviewed Study to Credit Xenex Germ-Zapping Robots for Infection Rate Decrease

A new study published in the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC), reports that the use of pulsed xenon ultraviolet (UV) light technology enabled Westchester Medical Center (Valhalla, NY) to reduce hospital acquired Clostridium difficile (C.diff) infection rates in its intensive care unit (ICU) by 70 percent. This is the fourth peer-reviewed study showing a decrease in patient infection rates as a result of a hospital’s utilization of Xenex Disinfection Services’ pulsed xenon UV room disinfection technology.

Xenex Germ-Zapping Robots™ use pulsed xenon Full Spectrum™ UV light to destroy viruses, bacteria and bacterial spores, including C.diff, in a five-minute disinfection cycle. Designed for speed, effectiveness and ease of use, hospital cleaning staff integrate Xenex robots into a hospital’s existing operations and hospital acquired infection (HAI) reduction strategy.

According to the study “Clostridium difficile infections before and during use of ultraviolet disinfection,” Nagaraja, A, et al. AJIC ePrint July 2015, the hospital experienced a 70 percent decrease in hospital acquired C.diff infection rates in its adult ICU during the utilization of the Xenex pulsed xenon UV device.

C.diff is a serious intestinal infection that can cause severe diarrhea, colitis and even death. According to the CDC, C. difficile caused almost half a million infections in the United States in 2011, and 29,000 people died within 30 days of the initial diagnosis. Many hospital patients, especially those on antibiotics, are susceptible to C.diff, which can live for up to five months on surfaces in the hospital. A person with C.diff may contaminate their hospital room and bathroom, leaving C.diff spores on the walls, handles and other high-touch surfaces that can be easily transferred to the next patient or healthcare worker in that room.

“There is no doubt that pulsed xenon UV disinfection technology is effective at helping hospitals reduce HAI rates. The C.diff infection rate reduction at Westchester Medical Center is similar to what we’ve heard from dozens of hospitals that are using Xenex germ-zapping robots for room disinfection,” said Morris Miller, CEO of Xenex. “Xenex offers the only UV disinfection technology that utilizes pulsed xenon to create germicidal UVC light and is the only UV disinfection technology shown, in peer reviewed published studies, to be effective in reducing HAI rates. We believe so strongly in our technology that we are willing to invest in our customers’ success. We recently announced a HAI Reduction Guarantee for hospitals and health systems that are looking for a proven solution to reduce their infection rates.”

Westchester Chose Pulsed Xenon UV over Mercury UV Because of Room Treatment Time According to the study’s authors, the hospital chose to use pulsed xenon UV instead of continuous mercury UV because of Xenex’s shorter cycle time. The study states, “Mercury bulbs emit a continuous low pressure light at a single range of 254 nm, and the effect of this UV light is cumulative requiring a longer cycle time of approximately 45 minutes for spore reduction. Pulse xenon UV disinfection emits a broad range of UV light from 200-280 nm in a high-intensity pulsatile manner, and the recommended average treatment time is approximately 18 minutes (per room).

Pulsed xenon devices also are somewhat safer because mercury-based devices can release toxic gases if they break accidentally. We choose to use the pulse xenon device because of the shorter cycle time.”

“We congratulate the Westchester Medical Center team on these outstanding results,” said Dr. Mark Stibich, Chief Scientific Officer of Xenex. “This is the twelfth peer-reviewed study proving the efficacy of pulsed xenon UV for room disinfection. Not all UV light is the same and only Xenex’s pulsed xenon UV technology has been capable of delivering HAI reduction results that stand up to peer review. As hospital decision-makers evaluate UV systems, we strongly encourage them to practice evidence-based medicine and look to the published literature as a guide.”

Only UV Disinfection System Proven to Reduce HAIs

MD Anderson Cancer Center, the Central Texas Veterans Health Care System, Cooley Dickinson Health Care (an affiliate of Massachusetts General Hospital and Partners HealthCare System) and other hospitals have published 12 studies providing evidence of the Xenex robot’s efficacy in highly regarded scientific journals that include the American Journal of Infection Control (AJIC), Journal of Infection Prevention, Infection Control & Hospital Epidemiology (ICHE) and BMC Infectious Diseases. These studies from hospitals that purchased Xenex robots report greater than 50 percent decreases in MRSA and C.diff infection rates in peer-reviewed literature, documenting how they used the Xenex robot in their real-world hospital environment to reduce infection rates.

Source: http://www.pharmiweb.com/PressReleases/pressrel.asp?ROW_ID=123451#.VcDnbrV8rCo

July 29th 2015 back

A pair of biotech VCs take aim at raising SA’s status more

BiO2 Medical raises $4M for device that prevents embolism more

How SA landed Cytocentrics more

Sandalwood firm sticks to forecasts more

Two New Studies Show Decrease in Hospital Acquired Infections after Xenex Germ-Zapping Robots Used for Room Disinfection more

Xenex Offers Industry’s First HAI Reduction Guarantee; Multiple Hospitals Report Decrease in Infection Rates When Using Xenex Germ-Zapping Robots for Room Disinfection more

Xenex to expand sales of ‘germ-zapping robots’ to more European nations more

West Australian Indian sandalwood oil producer purchases American drug companies more

Sandlewood grower to buy US-based pharmaceutical firms more

Cytocentrics has big plans for San Antonio more

TFS Corporation Limited jumps on acquisitions: What you need to know more

Australian firm acquires multiple San Antonio bioscience companies; Deal could be worth $270 million more

TFS To Acquire ViroXis And Santalis Pharma - Quick Facts more

DNAtrix Collaborators Present Data on a Novel Oncolytic Adenovirus Expressing OX40 Ligand that Promotes Antitumor Immunity more

San Antonio expected to become bigger global research player as result of Cytocentrics deal more

Cytocentrics Wins $1 Million Incentive and Warm Welcome to San Antonio more

San Antonio approves major incentive deal to lure German biotech firm more

German Biosciences Company Relocating Headquarters to San Antonio more

Cytocentrics looking to relocate HQ to San Antonio, create 300 jobs more

Cytocentrics CEO: Biotech company passed up bigger financial offers to move to San Antonio more

Milwaukee VA center cleared to use germ-zapping robots more

GAO Affirms VA Contract for Mercury-Free UV Disinfection System, Milwaukee VA Hospital Orders Xenex Full-Spectrum™ Germ-Zapping Robots™ more

Pivotal Investigation of BiO2 Medical's Angel Catheter Exceeds Enrollment Expectations more

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer more

Here’s why these 4 companies are soaring higher today more

Harvard gets wood more

2 Works for You helps teen diagnosed with brain cancer denied access to experimental treatment more

Harvard University sees the good oil in NT sandalwood plantation more

San Antonio bioscience companies to team up on critical research more

Germ-zapping R2-D2 look-alike works at Renown more

Are TFS Corporation Limited shares an absolute bargain? more

Med tech start-up exits Bank of Ireland Seed Fund with US$21m valuation more

Galway-based NeoSurgical exits Kernel Capital more

Xenex sells Germ-Zapping robot to Iowa nonprofit hospital more

Broadlawns Employs Xenex Robot to Eradicate Germs more

Benzac® Acne Solutions Premieres Its First-Ever “Insta-Dramedy” Webseries more

Sandalwood grower enlists F1 star more

StemBioSys closes $8m in funding to help launch its stem cell culture system more

Irish start-up neoSurgical has just signed an exclusive distribution deal for the US market. But, as founder and CEO Barry Russell explains, it has taken persistence and courage to get the company this far more

Xenex exporting hospital-cleaning robots to Europe more

Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection more

Takes $8M to Build Homes For Stem Cells more

San Antonio biomedical company StemBioSys scores major funding more

Lexington Fire Department chosen to conduct trial on new EMS Equipment more

Xenex Rebuts Clorox Attack Following NAD Press Release more

San Antonio’s Xenex files lawsuit against Cloroxn more

Lexington Fire Dept. Among First In Kentucky Testing New Device more

Here’s why today is a good day to buy TFS Corporation Limited shares more

Over-the-counter (OTC) remedies rescue consumers from skin and health issues that are—at the time—more pressing than fine lines and wrinkles more

Germ-zapping Dalek-like robots trialed at King’s Lynn’s Queen Elizabeth Hospital to reduce the spread of infection more

Seven Women Run Tech Startups in San Antonio to Watch more

UV light from robots disinfects hospital rooms more

TFS rises on upgraded guidance more

Biological assets boost valuation for TFS more

NPSF Patient Safety Coalition Welcomes Xenex more

UV Disinfection Equipment Market is Expected to Reach $2.8 Billion by 2020 – Allied Market Research more

Scent of success more

BiO2 Medical Begins Enrollment for the Pivotal Investigation of the Angel® Catheter more

Baptist Health's new germ-zapping robots use untraviolet light as a disinfectant more

Baptist Health adds "cleaning robots" more

The Only Full Spectrum™ Pulsed Xenon UV Disinfection System more

Benzac® Acne Solutions Launches in the US more

State of health care: Xenex CEO says company is winning war against deadly infections more

The Health Cell to present event focusing on San Antonio’s health care and biosciences sector more

San Antonio developing biotech executive talent more

Xenex’s latest funding exceeds expectations, expands international opportunities more

San Antonio bioscience company Xenex secures major funding more

Germ-Zapping Robot Makes House Call for Texas Baby more

Hospitals name their disinfecting robots to add personality more

The robot will clean up now: More hospitals buying automated systems to reduce infections more

New Study Shows Pulsed Xenon UV Light Effective in Reducing C. diff, MRSA and VRE in the Hospital Environment more

Forecast: Three San Antonio biomedical companies to watch in 2015 more

Here’s why these 4 stocks are soaring higher today more

Sandalwood the good oil for US funds more

Oil Investment Could Put A Smile On The Faces Of Harvard Students more

Harvard takes stake in TFS more

Aromatherapy at home can be easy more

TFS up on US acne product launch more

BiO2 Medical Receives IDE Approval to Initiate Pivotal Investigation of the Angel® Catheter more

StemBioSys Inc. to Present at Biotech Showcase™ 2015 more

Galderma Laboratories Launches Its First Over-the-Counter Acne Regimen, Benzac® Acne Solutions more